Abstract-Rotator cuff injuries frequently require surgical repairs which have a high failure rate. Biological augmentation has been utilized in an attempt to improve tendon repair. Poly-N-acetyl glucosamine (sNAG) polymer containing nanofibers has been shown to increase the rate for healing of venous leg ulcers. The purpose of this study was to investigate the healing and analgesic properties of sNAG in a rat rotator cuff injury and repair model. 144 adult male Sprague-Dawley rats underwent a transection and repair of their left supraspinatus tendons. Half of the animals received a sNAG membrane on the tendon-to-bone insertion site. Animals were further subdivided, receiving 1 or 3 days of analgesics. Animals were sacrificed 2, 4, or 8 weeks postinjury. Animals sacrificed at 4 and 8 weeks underwent longitudinal in vivo ambulatory assessment. Histological properties were assessed at 2, 4, and 8 weeks, and mechanical properties at 4 and 8 weeks. In the presence of analgesics, tendons receiving the sNAG polymer had significantly increased max load and max stress at 4 weeks, but not at 8 weeks. Ambulatory improvements were observed at 14 days in stride length and speed. Therefore, sNAG improves tendon-to-bone healing in a rat rotator cuff detachment and repair model.
INTRODUCTION
Rotator cuff injuries are a common musculoskeletal problem frequently requiring surgical intervention to restore shoulder function and decrease pain. Although advancements in surgical techniques and rehabilitation protocols have been made, this procedure continues to have a high failure rate. 7 The tendon-to-bone repair site consists primarily of fibrotic scar tissue, which is mechanically inferior to native tissue.
Biological augmentation can take several forms including the use of patient-derived growth factor enriched platelet-rich plasma (PRP) and autologous cell delivery such as mesenchymal stem cells (MSCs). However, these therapies are not well-established. Both approaches have shown mixed results in tendon repair, and there is little clinical evidence that patient-derived materials can reliably improve healing over a diverse patient population. 5, 10, 28 Due to the variability in cells and plasma obtained from the patient population, there is a need for additional biological materials with which to augment tendon healing. Poly-N-acetyl glucosamine (sNAG) polymer containing nanofibers has been shown to interact with tissues and cells and facilitate downstream responses. Unlike previously discussed materials, this polymer is produced by oceanic microalgae (Talymed Ò , Marine Polymer Technologies Inc., Burlington, MA, USA). sNAG has been shown to mediate red blood cell aggregation due to its ionic interactions with cell-surface proteins 23 which in turn can activate platelets. 24 Adherence of biomaterials to human tissues is an important aspect of augmentation success, and is dependent on a net positive charge of the material. The positive surface charge of sNAG is similar to that of human skin, 17 promoting strong adhesion. In a mouse cutaneous injury model, sNAG was shown to decrease scarring and increase failure load by immune activation via Akt1 signaling. 16 Clinically, sNAG membranes have been shown to accelerate the rate of healing in venous leg ulcers, with an 86% success rate. 12 Animal studies utilizing this material for diabetic wound healing indicate enhanced cell migration, cell metabolic rates, vascularity within wound beds, and inflammatory cell recruitment. 21 These findings suggest that this material might also be helpful in tendon healing. Additionally, N-acetyl glucosamine is part of the glycosaminoglycan family that has been demonstrated to provide pain relief from osteoarthritic knee pain and stiffness. 19, 26 There is anecdotal evidence that this material may possess analgesic effects when applied directly to a tissue (personal communication with Vournakis and Finkelstein 2016). As non-steroidal antiinflammatory drugs have been implicated in impairment of rotator cuff healing, 4 and opioid dependency can develop during surgical pain management, 13 there is a need for alternative analgesic approaches.
Therefore, the purpose of this study was to investigate the potential healing and analgesic properties of sNAG membranes in a rat rotator cuff tendon injury and repair model. We hypothesized that sNAG would improve tendon-to-bone healing and reduce pain in animals after supraspinatus detachment and repair.
MATERIALS AND METHODS

Study Design
144 adult male Sprague-Dawley rats (400-450 g) were used in this University of Pennsylvania Institutional Animal Care and Use Committee approved study. Animals were housed in a conventional facility in 12-h light/dark cycles and were fed standard rat chow ad libitum. All animals underwent a full thickness transection and repair of the left supraspinatus tendon. 1, 4 Prior to surgery, animals were randomized into treatment groups. Half of the animals received a standard repair, while the other half the animals received a thin membrane of sNAG (4 mm diameter) placed on the ''foot print'' of the supraspinatus tendon to bone insertion. The sNAG membrane is a very thin, dry construct that, when introduced to saline or bodily fluids, adheres and integrates within seconds. It is not difficult to place the membrane and the immediacy of integration is observed by the change in color from opaque/white (when dry) to translucent. This membrane is a composite of short polysaccharide polymer (pGlcNAc) fibers, isolated from microalgae. Native diatom-derived fibers have an average length of 80-100 lm and mean molecular weight of approximately 3,000,000 Da. Fibers are gamma irradiated, resulting in shorter, biodegradable nanofibers with an average length of 4-7 lm and approximate molecular weight of 60,000 Da. 27 After animals were split into sNAG and non-sNAG groups, they were further subdivided, receiving only 1 day of analgesics (buprenorphine) on the day of surgery or receiving the standard 3 days of analgesics. Therefore, animals were randomized into one of four groups receiving: (1) only 1 day of buprenorphine and no sNAG (1DB.NS), (2) the standard 3 days of buprenorphine and no sNAG (3DB.NS), (3) 1 day of buprenorphine with sNAG (1DB.S), and (4) 3 days of buprenorphine with sNAG (3DB.S). All groups were allowed normal cage activity after surgery. Animals were sacrificed at either 2 (n = 4 per group), 4 (n = 16 per group), or 8 weeks (n = 16 per group) post-injury and repair. Those sacrificed at 2 weeks underwent histological analysis only, while animals sacrificed at 4 and 8 weeks underwent either quasi static mechanical testing (n = 12 per group), or histological analysis (n = 4 per group) and longitudinal in vivo ambulatory assessments with measurements 1 day pre-injury and 3, 7, 14, 28, 42, and 56 days postinjury and repair. 9 
Detachment and Repair Surgery
All animals underwent a full thickness transection and repair of the left supraspinatus tendon as described previously.
1 Buprenorphine (0.05 mg/kg) was administered subcutaneously 30 min prior to surgery and 6-8 h post operatively in the groups receiving 1 day of analgesics. The standard analgesics group received the same doses on day one, followed by a dose every 12 h for the next 48 h. Briefly, with the left forearm held in external rotation and adduction, the deltoid muscle was split transversely to expose the supraspinatus tendon. The tendon was grasped using double-armed 5-0 polypropylene suture (Surgipro II, Covidien, Mansfield, MA) and was sharply transected from its insertion on the humeral head. For repair, a 5 mm diameter high speed bur (Multipro 395, Dremel, Mt. Prospect, IL) was used to remove remaining fibrocartilage from the footprint of the tendon insertion site. A 0.5 mm bone tunnel was drilled anterior to posterior through the greater tuberosity of the humerus. The suture was passed through the bone tunnel and tied down, affixing the tendon to the greater tuberosity using a modified Mason-Allen technique. Before tightening the suture for repair in the groups receiving sNAG (1DB.S and 3DB.S), a 4 mm diameter circle of Talymed Ò was placed over the insertion site, apposed between the tendon and bone interface (Fig. 1) . The size of the construct was consistently achieved by removing circles with a 4 mm biopsy punch at the time of surgery. The surgical site was flushed with saline, and the deltoid and skin was sutured closed with 4-0 Vicryl suture (Ethicon, Bridgewater, NJ).
Quantitative Ambulatory Assessment
Ground reaction forces (medial/lateral, vertical, braking, propulsion) and temporal spatial parameters (step length and width) were measured using an instrumented walkway. 20 Measurements were taken longitudinally, and included baseline measures taken 1 day pre-injury and then at 3, 7, 14, 28, 42, and 56 days post-injury and repair. Parameters were averaged across walks on a given day. Ground reaction force measurements were normalized to body weight.
Tendon Mechanical Testing
Animals sacrificed at 4 and 8 weeks (n = 12 per group) were frozen at 220°C and later thawed for dissection at the time of quasi-static mechanical testing. 2, 20 Left supraspinatus and humerus tendon-bone units were dissected from each rat and cleaned of excess soft tissue under a stereomicroscope. Stain lines were placed along the length of the tendon using Verhoeff's stain for optical strain measurement, starting at the insertion and continuing at 2 mm increments along the tendon. Cross sectional area was measured at the insertion, and at the 2 and 4 mm stain lines using a custom laser device as previously described. 6 These measurements are averaged to encompass both the tendon insertion and midsubstance. The humerus and humeal head were embedded in polymethylmethacrylate (PMMA) and held in a custom fixture in 90°a
bduction. The end of the tendon was fixed between fine grit sand paper using cyanoacrylate and then fixed in a custom grip. Samples were immersed in a 37°C PBS bath and subjected to a uniaxial tensile mechanical testing protocol consisting of a preload to 0.08 N, ten cycles of preconditioning (0.1-0.5 N at 1% strain/ s), a stress relaxation to 5% strain (5%/s) followed by a 600 s hold, and finally a ramp to failure at 0.3%/s. Maximum stress was calculated as force divided by cross sectional area and 2D Lagrangian optical strain was determined from stain line displacements measured from images taken throughout the test using custom tracking software. 2 Hence, reported mechanical properties are reflective of the tendon insertion and the midsubstance collectively. Samples were excluded from failure parameters (maximum load and maximum stress) if they did not fail in a physiologically relevant manner. We define physiologically relevant to be failure at the injury site (tendon-to-bone insertion) or in the tendon midsubstance.
Histological Analysis
Histological analysis was performed on animals sacrificed at 2, 4, and 8 weeks (n = 4 per group) to assess cell shape, cellularity, and collagen fiber organization at the injury site and midsubstance of the repaired supraspinatus tendon. At the time of sacrifice, supraspinatus-humerus units were immediately dissected, fixed in formalin, and processed using standard paraffin techniques. 7 lm sections were stained with hematoxylin and eosin (H&E) to assess cell shape, cellularity, and collagen fiber orientation at both the tendon insertion (injury site) and midsubstance. Cell shape and cellularity were evaluated by three blinded graders using a semi-quantitative method. Images were graded on a scale between 1 and 3 for both measures (where 1 = fewer cells/more rounded shape and 3 = greater number of cells/more spindle shaped)., At least 2 images per region were assessed per specimen. Grading standards were created within the set of images at each time point. A representative image was selected for each tertile to create grades of 1, 2, and 3. Images were then randomly organized and blinded for grading. Each grader compared each histological image to the representative images and selected the appropriate grade. This grading technique minimizes intra-tester variability, as representative images are pre-selected for grade determination instead of using descriptive terminology to select grades. Grades between graders were then compared. If an image received grades that were more than one grade apart (in this case, a 1 and a 3), all graders were asked to reassess his/her selected grade, without knowledge of the grade previously assigned. If grades still did not meet the criteria of a ±1 range from one another, the image was excluded. This grading technique minimizes intertester variability. 11, 15, 18, 22 Circular standard deviation of collagen fibers was determined by images taken with a polarizing microscope and analysis with custom software as described previously. 8, 9, 25 Statistical Analysis Sample sizes were determined using a priori power analyses. Statistical comparisons were made between 1DB.NS and 1DB.S (to test the effect of sNAG on tendon to bone healing with abbreviated analgesics), 3DB.NS and 3DB.S (to test the effect of sNAG on 
, e-h). At 4 weeks, only a small number of data points were excluded, and they were distributed similarly for each group (e, f). At 8 weeks, a large percentage of samples were affected (up to 58% per group). Here, distribution of excluded data are not uniform (g, h), in turn skewing the max load and max stress data for 3DB.S towards lower overall average values. Black bars represent mean 6 SD. 1DB.NS: 1 day of buprenorphine, no sNAG; 3DB.NS: 3 days of buprenorphine, no sNAG; 1DB.S: 1 day of buprenorphine, with sNAG; 3DB.S: 3 days of buprenorphine, with sNAG.
tendon to bone healing with standard analgesics), and 1DB.S and 3DB.S (to test the effect of sNAG in the presence of abbreviated vs. standard analgesics) at each time point. Mechanical testing comparisons were made using two-tailed t tests at each time point. Histological comparisons were made using non-paramet- ric Scheirer-Ray-Hare tests with follow up MannWhitney tests. Ambulatory assessment comparisons were made using a 2-way ANOVA with repeated measures and post hoc pair-wise comparisons with Bonferroni corrections at each time point. Multiple imputations were performed to replace missing data points (~10% per time point) necessary for repeated measures analysis. Significance was set at p £ 0.05, with trends set at p < 0.1.
RESULTS
Tendon Mechanical Properties
Differences in some mechanical properties were observed between groups with and without sNAG that received 3 days of analgesics (3DB.NS and 3DB.S) (Fig. 2) . Specifically, in the presence of analgesics, tendons receiving the sNAG polymer had significantly increased max load (Fig. 2a) and max stress (Fig. 2b) at 4 weeks compared to tendons without sNAG. At 8 weeks, max load (Fig. 2a) was significantly decreased and max stress (Fig. 2b ) trended toward decreased with the addition of sNAG. No differences in tendon modulus or stiffness were detected (Figs. 2c and 2d) . Additionally, no changes in tendon cross-sectional area or percent stress relaxation were identified across treatment groups (Figs. 2e and 2f ). Failure data (maximum load and maximum stress) excluded samples that failed at the grip (n = 13) or growth plate (n = 4). These data are represented in Fig. 3 , with full data sets shown on the right (Figs. 3e-3h , excluded values indicated by red markers) and analyzed data shown on the left. Non-physiological mechanical failure does not indicate the true maximum load values of the healing tendon, and were therefore excluded from analyses. At 4 weeks, only a small number of data points were excluded, and they were distributed similarly for each group (Figs. 3e and 3f) . At 8 weeks, a large percentage of samples were affected (up to 58% per group) and importantly, the distribution of excluded data are not uniform (Figs. 3g and 3h) , skewing the max load and max stress data for 3DB.S towards lower overall average values. Examples of excluded/included failure types are shown in Supplemental Fig. 1 .
Similar to the use of sNAG in the presence of analgesics, maximum stress trended toward an increase at 4 weeks when comparing groups with and without sNAG when only 1 day of analgesics was provided (Fig. 2b, 1DB .NS vs. 1DB.S).
Some differences were also identified between analgesic groups in the presence of sNAG. At 4 weeks, max load was also significantly greater for animals receiving both 3 days of analgesics and sNAG when compared to 1 day of analgesics and sNAG (Fig. 2a, 3DB .S vs. 1DB.S). Max stress also trended toward an increase for this comparison (Fig. 2b, 3DB .S vs. 1DB.S). Overall, the use of analgesics alone did not have an effect on mechanical properties (1DB.NS vs. 3DB.NS). No differences were seen between any groups in other mechanical parameters (cross-sectional area, stiffness, modulus, or % relaxation; Figs. 2c-2f ).
Histological Analysis
No significant differences were detected between treatment groups at any time point based on the power available in this study. Significant differences were seen across time in insertion and midsubstance cellularity (Figs. 4a and 4b, Supp Fig. 2) . Similarly, cell shape trended toward more spindle shaped across time at the insertion (Fig. 4c) . Collagen organization was increased (decreased CSD) at 8 weeks in the insertion of the 3DB.S group compared to the 1DB.S group (Fig. 5a ). No differences were seen in collagen organization at other time points (Supp Fig. 3 ).
Quantitative Ambulatory Assessment
There were no significant differences between any groups for measurements of medial lateral force, propulsion force, braking force, and vertical force. Stride width and stride length of the uninjured limb were also not different between groups. Speed of the injured left limb demonstrated that at 3 days, rats that were still receiving analgesics walked faster regardless of the presence of sNAG (Fig. 6a, 3DB .S vs. 1DB.S). This group continued to show increased speed at 28 and 56 days. Additionally, animals who received 3 days of analgesics walked faster in the presence of sNAG than those without (Fig. 6a, 3DB .S vs. 3DB.NS) at both 7 and 28 days.
Similarly, stride length of the injured left front limb demonstrated that at 3 days, rats still receiving analgesics have longer strides than those with only one day of analgesics, regardless of sNAG (Fig. 6b, 3DB .NS vs. 1DB.NS and 3DB.S vs. 1DB.S).
Lastly, at 7 days, rats with sNAG load their injured limb faster regardless of analgesics (Fig. 6c, 3DB .S vs. 3DB.NS). This parameter was also increased at later time points for animals receiving sNAG without extended analgesics (Fig. 6c, 1DB .S vs. 1DB.NS). Modest differences were also identified in functional assessments pre-operatively.
DISCUSSION
This study determined the effect of sNAG on tendon-to-bone healing and the potential analgesic properties of sNAG containing membranes in a rat rotator cuff tendon injury and repair model. Overall, results suggest that sNAG has positive effects on tendon strength during early healing in a rat rotator cuff model. Animals treated with sNAG showed an increase in max load and max stress at 4 weeks, demonstrating that the presence of this polymer improves the mechanical strength of the repaired tendonto-bone healing construct in relatively early healing. Given that the primary complication of rotator cuff repair surgery is early retear, these findings are particularly important. Although decreases in these mechanical properties were identified in sNAG treated groups at 8 weeks, we do not believe that the data support the idea that sNAG is detrimental at later stages of healing. This is due to a cluster of samples in the 3DB.S group that failed at higher loads requiring exclusion from the data analysis after non-physiological failure. In fact, these tendons may have failed physiologically at much higher loads than were measured. As tendons heal over time, the strength of the insertion and midsubstance increase, and limitations in the testing mechanism can cause failure at the site of the grip due to a stress concentration at this location. These excluded samples specifically affect failure data (maximum load and maximum strain). Therefore, we believe there are no important differences in tendon mechanics with or without sNAG at 8 weeks.
Overall, mechanical differences were observed between groups treated with and without sNAG along with 3 days of analgesics (3DB.NS vs. 3DB.S), and between groups receiving sNAG but receiving different time courses of analgesics (1DB.S vs. 3DB.S). Modest ambulatory differences were also identified between these groups. We have previously demonstrated the ability to improve post-operative ambulation with the use of analgesics.
3 Therefore, the combined observations in both mechanical and ambulatory metrics could be a result of differences in both pain and structural deficit. Taken together, these results do not support an analgesic effect in this model. A significant increase in collagen organization (decreased CSD) at 8 weeks in the insertion of the 3DB.S group compared to the 1DB.S group also suggests that sNAG was likely not able to replace the analgesic effects of buprenorphine. We suggest that without buprenorphine, changes in cage activity during early healing processes may have impacted long-term matrix remodeling. Although many different biological agents have been utilized in attempts to decrease retear rates after rotator cuff repair, there is little clinical evidence that patient-derived materials can reliably improve healing over a diverse patient population. For example, Dolkart et al. utilized the rat rotator cuff repair model and injected PRP into the intraarticular space. Three weeks post-operatively, load failures, stiffness, and histological parameters were enhanced with the addition of PRP. 2 On the other hand, Weber et al. reported no significant differences in pain, range of motion, or structural integrity after administering platelet-rich fibrin matrices in all size rotator cuff tears in a patient cohort. 28 Delivery of MSCs has shown promising results, but cell quality can be variable based on numerous patient characteristics. A long-term study reported that 100% of patients who received bone marrow derived MSCs (BM-MSCs) had intact rotator cuffs at 6 months post-op, compared with 67% of those who did not receive BM-MSCs. These results were consistent over 10 years post-op, with intact cuffs maintained in 86% of BM-MSC recipients compared to 44% in the control group. 10 This study identified a new treatment application for sNAG polymer, a product isolated from microalgae. Previous pre-clinical and clinical studies have demonstrated improved wound healing with sNAG treatment, and Talymed Ò is currently indicated for management of wounds including diabetic ulcers, burns, abrasions and lacerations, and pressure wounds. 12, 21 Our study, the first that investigates the effects of internal use of sNAG polymer after a musculoskeletal injury, suggests that this material also improves early tendon-to-bone healing in the rat rotator cuff. Unlike other forms of rotator cuff biological augmentation, no secondary procedures are needed to isolate cells or blood from the patient at the time of surgery. sNAG polymer sheets require no preparation, are stable at room temperature, and are non-immunogenic. Additionally, the material is thin and shows strong adherence to wound beds, unlike other materials that prevent healing due to thickness or unknown growth factor availability over time.
14 Although important differences were identified in tendon strength and temporal/spatial gait parameters, no differences were seen in tendon cross-sectional area, stiffness, modulus, or percent relaxation. Additionally, no differences were uncovered between groups for cell morphology or cell density, or for ground reaction forces assessed during ambulation analysis. We hypothesize that the effects of this treatment may be localized to the site of sNAG placement at the tendonto-bone insertion, as improved integration at this site could increase maximum load without impacting other parameters. Additional studies to assess bone properties and fibrocartilage formation at the insertion would provide further evidence to test this hypothesis.
This study has some limitations that should be acknowledged. First, though the rat rotator cuff repair model is well established and used extensively for such studies, quadruped models do not exactly imitate clinical scenarios. Second, this study used an acute supraspinatus detachment and repair although clinically, rotator cuff tears are commonly chronic subsequent to frequent overhead motions and overuse. However, we are using a well-established rat surgical and repair model as well as other well-established assays. Our methods are repeatable and the inclusion of longitudinal functional assays allow for improved clinical relevance. Third, because the method of administration for sNAG is the placement of a quickly dissolvable membrane, we are unsure of the exact distribution of sNAG after delivery. Utilizing a tagged polymer that can be tracked over time would provide the confirmation of material maintenance at the site of healing. Polymer uptake and clearance may also diminish the effects of this treatment. The sNAG degradation rate in the tendon environment has not been determined, as this is dependent on several variable including polymer molecular weight, material thickness, and implantation site. However, given all the differences quantified in this study, we are confident that the sNAG was present for important phases of tendon healing. Further, the ability to understand pain relief in prey animals is imperfect. Although we combined ambulatory measurements with tendon structural and mechanical properties to best evaluate the presence of pain vs. loss of function, we acknowledge that this is a limited assessment.
This study evaluated the mechanical, histological, and functional properties of injured tendons with and without sNAG polymer delivery as well as in the context of analgesics. Overall, sNAG was shown to have positive effects on tendon strength during early healing, but no effects during later healing. Further, there was no confirmed analgesic effect as previously speculated in this model. Future studies should incorporate additional molecular characterization, which may elucidate the mechanism of action for the changes identified.
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